This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Helen Katherine Smith: Innovator in Selective 5HT Antagonists
Introduction
Helen Katherine Smith is a notable inventor based in Harlow, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various sleep disorders. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to improving health outcomes.
Latest Patents
Helen holds one patent related to a series of substituted bis aryl and heteroaryl compounds. The patent describes compounds that are selective 5HT antagonists, which are useful in treating a variety of diseases, including a wide range of sleep disorders. The specific formula and characteristics of these compounds are detailed in her patent, highlighting their potential therapeutic applications.
Career Highlights
Helen Katherine Smith is associated with Aventis Pharmaceuticals Inc., where she has been instrumental in advancing research and development in her field. Her work has not only contributed to the company's portfolio but has also had a broader impact on the pharmaceutical industry.
Collaborations
Some of her notable coworkers include Paul Robert Eastwood and Hazel Joan Hunt. Their collaborative efforts have likely enhanced the research environment and fostered innovation within their projects.
Conclusion
Helen Katherine Smith's contributions to the field of pharmaceuticals, particularly through her patent on selective 5HT antagonists, demonstrate her commitment to addressing critical health issues. Her work continues to inspire advancements in the treatment of sleep disorders and beyond.